am 251 and CB-13
am 251 has been researched along with CB-13 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Limebeer, CL; Mechoulam, R; Parker, LA; Rock, EM | 1 |
| Baker, D; Pryce, G | 1 |
Other Studies
2 other study(ies) available for am 251 and CB-13
| Article | Year |
|---|---|
The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.
Topics: Animals; Antiemetics; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Cerebral Cortex; Dronabinol; Lithium Chloride; Male; Naphthalenes; Nausea; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1 | 2012 |
Antidote to cannabinoid intoxication: the CB
Topics: Animals; Antidotes; Cannabinoid Receptor Agonists; Drug Inverse Agonism; Female; Hypothermia; Mice; Mice, Biozzi; Naphthalenes; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1 | 2017 |